Bioventus (BVS) Enters Settlement Agreement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Bioventus Enters into Settlement Agreement to Preserve Maximum Optionality – Up To $350mm of Potential Liability Reduction and a Release of Future Claims related to the CartiHeal Acquisition
February 28, 2023 7:30 AM ESTDURHAM, N.C., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (Bioventus or the Company), a global leader in innovations for active healing, announced today that it has entered into a Settlement Agreement (the Settlement Agreement) with the former CartiHeal shareholders (the CartiHeal Sellers) regarding the Companys obligations under the amended Option and Equity Purchase Agreement for its prior acquisition of CartiHeal (the Amended Acquisition Agreement).
The Settlement... More
